134 related articles for article (PubMed ID: 20223895)
1. TOP2 gene disruption reduces drug susceptibility by increasing intracellular ergosterol biosynthesis in Candida albicans.
Zheng H; Jiang YY; Wang Y; Jia XM; Yan TH; Gao PH; Yan L; Jiang LH; Ji H; Cao YB
J Med Microbiol; 2010 Jul; 59(Pt 7):797-803. PubMed ID: 20223895
[TBL] [Abstract][Full Text] [Related]
2. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.
Dunkel N; Liu TT; Barker KS; Homayouni R; Morschhäuser J; Rogers PD
Eukaryot Cell; 2008 Jul; 7(7):1180-90. PubMed ID: 18487346
[TBL] [Abstract][Full Text] [Related]
3. Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans.
Mukhopadhyay K; Prasad T; Saini P; Pucadyil TJ; Chattopadhyay A; Prasad R
Antimicrob Agents Chemother; 2004 May; 48(5):1778-87. PubMed ID: 15105135
[TBL] [Abstract][Full Text] [Related]
4. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.
Sanglard D; Ischer F; Parkinson T; Falconer D; Bille J
Antimicrob Agents Chemother; 2003 Aug; 47(8):2404-12. PubMed ID: 12878497
[TBL] [Abstract][Full Text] [Related]
5. Lovastatin synergizes with itraconazole against planktonic cells and biofilms of Candida albicans through the regulation on ergosterol biosynthesis pathway.
Zhou Y; Yang H; Zhou X; Luo H; Tang F; Yang J; Alterovitz G; Cheng L; Ren B
Appl Microbiol Biotechnol; 2018 Jun; 102(12):5255-5264. PubMed ID: 29691631
[TBL] [Abstract][Full Text] [Related]
6. Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux.
Saibabu V; Fatima Z; Singh S; Khan LA; Hameed S
J Mycol Med; 2020 Apr; 30(1):100921. PubMed ID: 31937429
[TBL] [Abstract][Full Text] [Related]
7. An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans.
Hoot SJ; Smith AR; Brown RP; White TC
Antimicrob Agents Chemother; 2011 Feb; 55(2):940-2. PubMed ID: 21078937
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.
Sun LM; Liao K; Liang S; Yu PH; Wang DY
J Appl Microbiol; 2015 Apr; 118(4):826-38. PubMed ID: 25641229
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria influence CDR1 efflux pump activity, Hog1-mediated oxidative stress pathway, iron homeostasis, and ergosterol levels in Candida albicans.
Thomas E; Roman E; Claypool S; Manzoor N; Pla J; Panwar SL
Antimicrob Agents Chemother; 2013 Nov; 57(11):5580-99. PubMed ID: 23979757
[TBL] [Abstract][Full Text] [Related]
10. Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants.
Sun N; Fonzi W; Chen H; She X; Zhang L; Zhang L; Calderone R
Antimicrob Agents Chemother; 2013 Jan; 57(1):532-42. PubMed ID: 23147730
[TBL] [Abstract][Full Text] [Related]
11. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
12. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
[TBL] [Abstract][Full Text] [Related]
13. Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant
Xu Y; Quan H; Wang Y; Zhong H; Sun J; Xu J; Jia N; Jiang Y
Front Cell Infect Microbiol; 2017; 7():491. PubMed ID: 29238700
[No Abstract] [Full Text] [Related]
14. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ
Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
[TBL] [Abstract][Full Text] [Related]
15. The effect of plagiochin E alone and in combination with fluconazole on the ergosterol biosynthesis of Candida albicans.
Sun LM; Lv BB; Cheng AX; Wu XZ; Lou HX
Biol Pharm Bull; 2009 Jan; 32(1):36-40. PubMed ID: 19122277
[TBL] [Abstract][Full Text] [Related]
16. The Aspergillus fumigatus Damage Resistance Protein Family Coordinately Regulates Ergosterol Biosynthesis and Azole Susceptibility.
Song J; Zhai P; Zhang Y; Zhang C; Sang H; Han G; Keller NP; Lu L
mBio; 2016 Feb; 7(1):e01919-15. PubMed ID: 26908577
[TBL] [Abstract][Full Text] [Related]
17. Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains.
Popp C; Hampe IAI; Hertlein T; Ohlsen K; Rogers PD; Morschhäuser J
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461316
[TBL] [Abstract][Full Text] [Related]
18. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
Reis de Sá LF; Toledo FT; Gonçalves AC; Sousa BA; Dos Santos AA; Brasil PF; Duarte da Silva VA; Tessis AC; Ramos JA; Carvalho MA; Lamping E; Ferreira-Pereira A
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821447
[TBL] [Abstract][Full Text] [Related]
19. Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans.
Prasad T; Hameed S; Manoharlal R; Biswas S; Mukhopadhyay CK; Goswami SK; Prasad R
FEMS Yeast Res; 2010 Aug; 10(5):587-96. PubMed ID: 20491944
[TBL] [Abstract][Full Text] [Related]
20. Ergosterol gene expression in wild-type and ergosterol-deficient mutants of Candida albicans.
Pierson CA; Eckstein J; Barbuch R; Bard M
Med Mycol; 2004 Aug; 42(4):385-9. PubMed ID: 15473366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
